These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21396929)

  • 21. Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
    Liang F; O'Rear J; Schellenberger U; Tai L; Lasecki M; Schreiner GF; Apple FS; Maisel AS; Pollitt NS; Protter AA
    J Am Coll Cardiol; 2007 Mar; 49(10):1071-8. PubMed ID: 17349887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of N-terminal proB-type natriuretic peptide.
    Costello-Boerrigter LC; Burnett JC
    Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pro-B-type natriuretic peptide is processed in the circulation in a rat model.
    Semenov AG; Seferian KR; Tamm NN; Artem'eva MM; Postnikov AB; Bereznikova AV; Kara AN; Medvedeva NA; Katrukha AG
    Clin Chem; 2011 Jun; 57(6):883-90. PubMed ID: 21474642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BNP as a biomarker in heart disease.
    Vuolteenaho O; Ala-Kopsala M; Ruskoaho H
    Adv Clin Chem; 2005; 40():1-36. PubMed ID: 16355919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
    Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.
    Semenov AG; Katrukha AG
    Clin Chem; 2016 Apr; 62(4):617-22. PubMed ID: 26864319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clearance of BNP modeled using the NT-proBNP-BNP relationship.
    Kroll MH; Srisawasdi P
    Biosystems; 2007 Mar; 88(1-2):147-55. PubMed ID: 16860926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical utility of NT-proBNP, a new biomarker of cardiac function and heart failure].
    Ishii J
    Rinsho Byori; 2008 Apr; 56(4):316-21. PubMed ID: 18516966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Clin Chim Acta; 2004 Mar; 341(1-2):41-8. PubMed ID: 14967157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies.
    McDonagh TA; Holmer S; Raymond I; Luchner A; Hildebrant P; Dargie HJ
    Eur J Heart Fail; 2004 Mar; 6(3):269-73. PubMed ID: 14987575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.
    Alehagen U; Goetze JP; Dahlström U
    Clin Chim Acta; 2007 Jul; 382(1-2):8-14. PubMed ID: 17433809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
    Halfinger B; Hammerer-Lercher A; Amplatz B; Sarg B; Kremser L; Lindner HH
    Clin Chem; 2017 Jan; 63(1):359-368. PubMed ID: 28062629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
    J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [BNP or NT-proBNP: "that is the question"].
    Lebrun C; Neuder Y; Pison C; Chouri N; Barnoud D; Belle L; Beaune G
    Ann Biol Clin (Paris); 2007; 65(5):533-8. PubMed ID: 17913672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.
    Bettencourt P; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):67-71. PubMed ID: 18243862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.
    Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M
    Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.